Today

Agents

Chat

Arena

Discover

More

App

Krystal Biotech Q2 Net Income USD 54.768 Million - KRYS News | Rallies

Krystal Biotech Q2 Net Income USD 54.768 Million

KRYS•2026-08-03

Q2 results

Aug. 3 (Reuters) - Krystal Biotech Q2 product revenue was USD 119.222 million.

Q2 net income: USD 54.768 million
Q2 operating expenses: USD 60.805 million
Q2 operating income: USD 58.417 million

Related News

Kilroy Realty Corporation <KRC.N>: BofA Global Research raises price objective to $46.00 from $44.00

KRC•2026-08-03

CrowdStrike says Fal.Con 2026 conference sells out at record pace amid AI security demand

CRWD•2026-08-03

KKR to take medical equipment maker Integer Holdings private in $5.7 billion deal

ITGR•2026-08-03

Hess Midstream Q2 FY26 net income falls 3.34% to $173.7 million

HESM•2026-08-03

NextPlat to report Q2 2026 results, host investor call

NXPL•2026-08-03